Condition: Polymyalgia Rheumatica (PMR) · Giant Cell Arteritis (GCA) · Sponsor: University Hospital, Basel, Switzerland
This prospective study is to explore different predictive factors for response to steroid treatment in patients with PMR and/or GCA. It evaluates the association of endogenous GC suppression (plasma and urinary cortisol and cortisone) to the responsiveness of PMR/GCA to GCs.
This description comes directly from the study's public registry record.
Thomas Daikeler, Prof. Dr. med. · +41 61 265 27 09 · Thomas.Daikeler@usb.ch
Always discuss trial participation with your own doctor first.
| Department of Rheumatology University Hospital Basel | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05479448